A Stock that Will Beat the 40% Gains in the Pharma Sector Hands Down

May 6, 2020

When I think of it now, it seems quite eerie.

On the 31st of December 2019, I recorded a video, at the Equitymaster office. At that time, somewhere in Wuhan, China, one of the first cases of Coronavirus was getting confirmed.

My video - The One Sector Set for Big Rebound in 2020 and Beyond - was on the big potential of the Indian pharma sector in 2020.

But like everyone else, I had not even heard of coronavirus until then.

Indian pharma companies already had a terrible few years thanks to their USFDA woes. Earnings had been very volatile. Valuations were at rock bottom. So, my optimism about the sector was not founded on the basis of any potential global pandemic.

Coronavirus or not, I knew a few pharma companies in India were all set to rebound.

But coronavirus or Covid-19, proved India's importance to the world for low cost generic drug production. Billions of dollars are now being poured into vaccine research.

But the job of making billions of vaccine doses available will still rest with low cost vaccine manufacturers. Some of them will certainly be from Indian pharma.

It is therefore of little wonder that Indian pharma stocks went up 30% to 70% in the past two months.

The BSE Healthcare index gained 40% even as every other index bled.

But you would be wrong to assume that drug manufacturers will be the biggest gainers in a post Covid-19 world.

Rather, the technology that will help diagnose patients and prescribe drugs, world over, will see exponential growth.

And it answers to the name of Telemedicine.

  India's Next War  
  Recently, both China and Pakistan have started amping up tensions at the border.

So, now India faces a possible 2-front war scenario.

And this calls for a heavy deployment of future-ready and highly advanced weapons at our borders.

We are talking next generation tanks, guns and even high-tech equipment like drones.

Now unlike in the past where all this money was spent with foreign companies, now, it's being redirected to Indian companies.

For a few Indian defence companies...this is a mega growth opportunity.

And for investors... it's a rare opportunity to make potentially huge gains as select defence companies see their growth, and therefore stock prices, potentially shoot up.

To learn everything about this new, and huge, opportunity, Click Here to join Equitymaster's Explosive Profits Summit.

At this exclusive summit, you will also get to access details of what we call our #1 defence stock pick.

It's a potential 10x opportunity in the long term.

We hate spam as much as you do. Please read our Privacy Policy & Terms Of Use.

By submitting your email address, you also sign up for Profit Hunter, a Free-for-life newsletter from Equitymaster, which offers the most profitable investing ideas in India

Telemedicine basically means offering virtual healthcare when the doctor and patient are at remote locations.

The technology equips diagnostic tools like BP apparatus, ECG, glucometer etc with artificial intelligence. It helps doctors diagnose patients and prescribe medicines.

Traditionally, telemedicine has been associated with providing better healthcare access to under-served communities, rural populations, and low-income groups.

But Covid19 has made it a new normal for urban areas too.

One of the niche technology companies I've been tracking for the past five years, has been innovating in the telemedicine space for a while.

#1 Small-Cap Stock: Biggest Opportunity in the Indian FMCG Market

It has published research papers on integrating medical science with augmented and virtual reality, 3-D printing, robotics, and advanced IoT and AI capabilities.

In the last few quarters, the company has been investing heavily into this vertical.

I am confident the business is currently at an inflection point. Especially, for its agility in capturing the opportunities in the post Covid-19 world.

I have explained my rationale in detail, in my special report.

Looking at the potential upside in the stock, over a period of five to ten years, I believe investors could become a One Stock Crorepati.

Warm regards,

Tanushree Banerjee
Tanushree Banerjee
Editor, StockSelect
Equitymaster Agora Research Private Limited (Research Analyst)

PS: Find out more about this exciting stock here.

Recent Articles

I Trust Tanushree to Do a Jim Rogers and Unlock Huge Gains from Defence Stocks October 19, 2020
The set up that made Jim Rogers famous is now up for grabs in India.
Why India's Drone Revolution is a 4x Profit Opportunity October 16, 2020
My research on India's leading defence companies brought me to one major player in drone manufacturing.
Here's How You Can Join India's Ascent in the Global Drone Revolution October 15, 2020
'The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.
The Biggest Wealth Creating Opportunity that No One is Talking About October 14, 2020
The defence sector has gone under the radar despite positive developments. Here's why this sector can't be ignored for long...

Equitymaster requests your view! Post a comment on "A Stock that Will Beat the 40% Gains in the Pharma Sector Hands Down". Click here!